Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.

The Journal of antimicrobial chemotherapy - 1 Oct 2008

O'Connor Rachael, Baines Simon D, Freeman Jane, Wilcox Mark H

Abstract excerpt

OBJECTIVES: Clostridium difficile infection is a nosocomial disease of increasing importance. First-line treatment is limited to metronidazole or vancomycin. Oritavancin is a lipoglycopeptide with activity against Gram-positive bacteria, including drug-resistant pathogens. MICs of oritavancin, metronidazole and vancomycin for genotypically distinct C. difficile strains, including epidemic C. difficile PCR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridioides difficile
Share to Culture Media

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Fingerprinting

Share to Enterocolitis, Pseudomembranous

Share to Glycopeptides

Share to Metronidazole

Share to Ribotyping

Share to Vancomycin

Source

Identifiers

PMID: 18606787
DOI: 10.1093/jac/dkn276

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.PMID 18606787Read ↗

Detection and Investigation of Eagle Effect Resistance to Vancomycin in Clostridium difficile With an ATP-Bioluminescence AssaySemantic proximity Read ↗

Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010Semantic proximity Read ↗

Challenges for Standardization of Clostridium difficile Typing MethodsSemantic proximity Read ↗

Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal originSemantic proximity Read ↗

Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes.Semantic proximity Read ↗

Hypervirulent Clostridium difficile PCR-Ribotypes Exhibit Resistance to Widely Used DisinfectantsSemantic proximity Read ↗

Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.Semantic proximity Read ↗

PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolatesSemantic proximity Read ↗

Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators.Semantic proximity Read ↗

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.Semantic proximity Read ↗

In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.Semantic proximity Read ↗

In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.